These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21374337)

  • 41. Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.
    Musselli C; Daverio-Zanetti S; Zanetti M
    J Immune Based Ther Vaccines; 2004 Nov; 2(1):9. PubMed ID: 15541175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of overexpression TCR Vbeta5.2-HSP70 and TCR Vbeta8.2-HSP70 against collagen-induced arthritis in rats.
    Xiao J; Li S; Wang W; Li Y; Zhao W
    Cell Mol Immunol; 2007 Dec; 4(6):439-45. PubMed ID: 18163955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
    Kumar V; Aziz F; Sercarz E; Miller A
    J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of collagen-induced arthritis by DNA vaccines encoding TCR Vbeta5.2 and TCR Vbeta8.2.
    Ge PL; Ma LP; Wang W; Li Y; Zhao WM
    Chin Med J (Engl); 2009 May; 122(9):1039-48. PubMed ID: 19493438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
    Kumar V; Tabibiazar R; Geysen HM; Sercarz E
    J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat.
    Chan A; Gold R; Giegerich G; Herrmann T; Jung S; Toyka KV; Hartung HP
    J Neurosci Res; 1999 Oct; 58(2):214-25. PubMed ID: 10502278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopathogenesis of collagen arthritis.
    Brand DD; Kang AH; Rosloniec EF
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell receptors: germline polymorphism and patterns of usage in demyelinating diseases.
    Usuku K; Joshi N; Hauser SL
    Crit Rev Immunol; 1992; 11(6):381-93. PubMed ID: 1382445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myelin basic protein, MHC restriction molecules and T cell repertoire.
    Vandenbark AA; Hashim G; Offner H
    Prog Clin Biol Res; 1990; 336():93-108. PubMed ID: 1691512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell receptor peptides as immunotherapy for autoimmune disease.
    Gold DP; Shroeder K; Golding A; Brostoff SW; Wilson DB
    Crit Rev Immunol; 1997; 17(5-6):507-10. PubMed ID: 9419437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell receptor usage in autoimmune disease.
    Olive C
    Immunol Cell Biol; 1995 Aug; 73(4):297-307. PubMed ID: 7493765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunity to T-cell receptor : suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor.
    Waisman A
    Methods Mol Med; 2000; 29():397-403. PubMed ID: 21374337
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.